Tevogen Bio (TVGN) Form 4 Semper Paratus Acquisition / SURENDRA K AJJARAPU ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

AJJARAPU SURENDRA K

(Last) (First) (Middle)

767 THIRD AVENUE

38TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Semper Paratus Acquisition Corp [ LGST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
CEO and Chairman

3. Date of Earliest Transaction (Month/Day/Year)
06/07/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares, par value $0.0001 per share(1)	06/07/2023		A		1,000,000	A	(2)	1,000,000	I	By SSVK Associates, LLC(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B ordinary shares, par value $0.0001 per share	(4)	06/07/2023		A		7,988,889(3)		(4)	(4)	Class A ordinary shares, par value $0.0001 per share	7,988,889	(2)	7,988,889	I	By SSVK Associates, LLC(3)
Warrants(5)	$11.5	06/07/2023		A		500,000(2)		(6)	(7)	Class A ordinary shares, par value $0.0001 per share	500,000	(2)	500,000	I	By SSVK Associates, LLC(3)

Explanation of Responses:

1. The Class A Ordinary shares are underlying the units (the "Private Placement Units"). As described in the Issuer's registration statement on Form S-1 (No. 333-260113) under the heading "Description of Securities - Units" each Private Placement Unit consists of one share of the Issuer's Class A ordinary shares and one-half of one redeemable warrant.

2. SSVK Associates, LLC the sponsor of the Issuer (the "Sponsor"), purchased all its interests in the Issuer, including certain other rights and obligations in accordance with a purchase agreement, dated as of May 4, 2023, entered into by and among, Reporting Person, the Issuer and other certain securityholders for an aggregate purchase price of $1 (one dollar) due on the date on which a business combination is completed.

3. The securities are held directly by the Sponsor. Surendra Ajjarapu, the Issuer's Chairman and Chief Executive Officer is the manager of the Sponsor. Mr. Ajjarapu may be deemed to beneficially own the securities held by the Sponsor by virtue of his control over the Sponsor. Mr. Ajjarapu disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his respective pecuniary interest.

4. As described in the Issuer's registration statement on Form S-1 (No. 333-260113) under the heading "Description of Securities-Founder Shares", the shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the Issuer's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date.

5. The Warrants are underlying the Private Placement Units. As described in the Issuer's registration statement on Form S-1 (No. 333-260113) under the heading "Description of Securities - Units" each Private Placement Unit consists of one share of the Issuer's Class A ordinary shares and one-half of one redeemable warrant.

6. The Warrants will become exercisable upon the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of the Issuer's initial business combination.

7. The Warrants will expire five years after the completion of the Issuer's business combination or earlier upon redemption or liquidation.

	/s/ Surendra Ajjarapu, by Nelson Mullins Riley & Scarborough LLP with Power of Attorney	06/12/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.